Research to date has shown that in vivo blockade of the GpIb–VWF axis resulted in the elimination of arterial thrombus formation in primates [7], restored vessel patency by dissolving platelet aggregates [8], and led to significantly reduced infarct volumes and better functional outcome in rodent stroke models [4]–[6] and larger animals [9]. The gene discussed is VWF; the disease is Stroke.